文献速递临床试验与 GCP流行病学与生物统计

平衡盐溶液与0.9%生理盐水输注预防造影剂诱导急性肾损伤的有效性和安全性(BASIC试验):随机对照试验研究方案

Efficacy and safety of a balanced salt solution versus a 0.9% saline infusion for the prevention of contrast-induced acute kidney injury (BASIC trial): a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-10-05

BASIC试验为多中心随机对照试验,拟招募接受增强CT并需预防造影剂诱导急性肾损伤(CI-AKI)的患者,比较平衡盐溶液与0.9%生理盐水在CI-AKI预防中的有效性和安全性;研究将评估CI-AKI发生率及肾脏替代治疗启动或全因死亡等长期结局。

要点

  • 多中心随机对照试验比较平衡盐溶液与0.9%生理盐水预防CI-AKI。
  • 研究对象为拟接受增强CT并需CI-AKI预防的患者。
  • 随访评估CI-AKI发生率及肾脏替代治疗启动或全因死亡等长期结局。

核心结论

  • 据研究者所知,该研究将是首个评估平衡盐溶液相对于0.9%生理盐水对CI-AKI预防价值的研究。
  • 若试验显示平衡盐溶液预防CI-AKI与0.9%生理盐水同样有效,则因平衡盐溶液较0.9%生理盐水减少代谢性酸中毒的可能性,可推广平衡盐溶液的使用。

研究设计与样本

  • 多中心随机对照试验,比较平衡盐溶液与0.9%生理盐水在CI-AKI预防中的有效性。
  • 研究招募计划接受增强计算机断层扫描(CT)并需CI-AKI预防的患者。
  • 参与者随机分为两组:研究组接受平衡盐溶液,对照组接受0.9%生理盐水。
  • 按方案在CT扫描前后给予液体,并通过采集血和尿样本评估基线临床状态。
  • 随访期间评估CI-AKI发生率及长期结局,包括开始肾脏替代治疗或全因死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Contrast-induced acute kidney injury (CI-AKI) is one of the most common causes of iatrogenic kidney injury and, therefore, its prevention is an important issue. However, whether the administration of 0.9% saline is the optimal prophylaxis method remains uncertain due to its supra-physiologic chloride component. In particular, recent studies suggest that chloride-restricted solutions showed superiority over 0.9% saline in several clinical settings. METHODS/DESIGN: The investigators designed a multicenter randomized controlled trial to compare the efficacy of a balanced salt solution and 0.9% saline in CI-AKI prophylaxis. This study will recruit patients who are scheduled for contrast-enhanced computed tomography (CT) scans with CI-AKI prophylaxis. In this study, participants will be randomized into two study arms; the study group will receive a balanced salt solution, and the control group will receive 0.9% saline. Fluids will be administered as designated in the protocol before and after the CT scan, and an evaluation of baseline clinical status will be performed by obtaining blood and urine samples. During the follow-up visits, the incidence of CI-AKI and long-term outcomes, including the start of renal replacement therapy or all-cause mortality, will be assessed. DISCUSSION: To our knowledge, this study will be the first study assessing the preventive value of a balanced salt solution over 0.9% saline for CI-AKI. If the trial shows that the balanced salt solution is as effective for CI-AKI prophylaxis as 0.9% saline, the use of the balanced salt solution could be promoted due to the reduced possibility of consequent metabolic acidosis compared to 0.9% saline. TRIALS REGISTRATION: ClinicalTrials.gov, ID: NCT02799368 . Registered on 14 June 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jo HA, Park S, Kim CD, et al. Efficacy and safety of a balanced salt solution versus a 0.9% saline infusion for the prevention of contrast-induced acute kidney injury (BASIC trial): a study protocol for a randomized controlled trial. Trials. 2017. PMID: 28982378. doi:10.1186/s13063-017-2202-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。